paperBiotech

From cytokine storm to renal scarring in diabetic kidney disease: Biomarkers, risk stratification, and precision therapeutics

From cytokine storm to renal scarring in diabetic kidney disease: Biomarkers, risk stratification, and precision therapeutics

publishedDate Venue Precision Medical Sciences

Source-permitted summary

From cytokine storm to renal scarring in diabetic kidney disease: Biomarkers, risk stratification, and precision therapeutics

SourceWiley

Verified by AISci

Public source attached

Source status for this paper in the current AISci reviewed snapshot.

Primary source
Wiley
Correction status
none
Evidence coverage
1 sources / 1 publishers
Last metadata check
Jul 19, 2026
Open primary source

AI Reading Notes

Core signal

Structured notes generated from source-linked AISci metadata. Treat them as a reading aid, not a substitute for the paper.

Core signal
From cytokine storm to renal scarring in diabetic kidney disease: Biomarkers, risk stratification, and precision therapeutics
Field context
Diagnostics and Biomarkers
People and labs
Not stated in the reviewed source.
Why it matters
Recent source-backed research output for AISci Stage A browsing.
Limits to check
AISci rank score does not assess scientific quality or citation impact.

Publication facts

Type
paperSourceWiley
Date
Jun 21, 2026SourceWiley
Venue
Precision Medical SciencesSourceWiley
Open access
unknownSourceWiley

External IDs

Author order

No reviewed author edge is attached to this output.

Organizations

No source-confirmed author affiliation is attached.

Related events

Topics

Relationship evidence

Timeline

  1. paperFrom cytokine storm to renal scarring in diabetic kidney disease: Biomarkers, risk stratification, and precision therapeutics